Psoriasis carries an increased risk of venous thromboembolism: A Danish nationwide cohort study

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ahlehoff, Ole ^a   Gislason, Gunnar Hilmar ^a   Lindhardsen, Jesper ^a   Charlot, Mette Gitz ^a   Jørgensen, Casper Haslund ^a   Olesen, Jonas Bjerring ^a   Bretler, Ditte Marie ^a   Skov, Lone ^a,b   Torp Pedersen, Christian ^a,b   Hansen, Peter Riis ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; VITAMIN D DERIVATIVE;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DANISH; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PSORIASIS; RACE; RISK ASSESSMENT; SOCIOECONOMICS; VENOUS THROMBOEMBOLISM; AGE DISTRIBUTION; CONFIDENCE INTERVAL; DENMARK; EPIDEMIOLOGY; HEALTH SURVEY; INCIDENCE; MIDDLE AGED; RISK FACTOR;

AGE DISTRIBUTION; BIAS (EPIDEMIOLOGY); COHORT STUDIES; CONFIDENCE INTERVALS; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PSORIASIS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79953065490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018125     Document Type: Article

References (33)

1. Nestle FO, Kaplan DH, Barker J, (2009) Psoriasis. N Engl J Med 361: 496-509.
2. Menter A, Griffiths CE, (2007) Current and future management of psoriasis. Lancet 370: 272-284.
3. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, et al. (2008) AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 102: 1631-1643.
4. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA, (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 190: 1-9.
5. Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, et al. (2008) Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 217: 27-37.
6. McDonald CJ, Calabresi P, (1978) Psoriasis and occlusive vascular disease. Br J Dermatol 99: 469-475.
7. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296: 1735-1741.
8. Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129: 2411-2418.
9. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, et al. (2009) Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 145: 700-703.
10. Mallbris L, Akre O, Granath F, Yin L, Lindelof B, et al. (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19: 225-230.
11. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, et al. (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31: 1000-1006.
12. Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, et al. (2010) Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern med doi: 10.1111/j.1365-2796.2010.02310.x. [Epub ahead of print].
13. Gisondi P, Girolomoni G, (2009) Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 35: 313-324.
14. Karabudak O, Ulusoy RE, Erikci AA, Solmazgul E, Dogan B, et al. (2008) Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol 88: 337-340.
15. Tamagawa-Mineoka R, Katoh N, Kishimoto S, (2010) Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. J Am Acad Dermatol 62: 621-626.
16. Goldhaber SZ, (2010) Risk factors for venous thromboembolism. J Am Coll Cardiol 56: 1-7.
17. Holst AG, Jensen G, Prescott E, (2010) Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 121: 1896-1903.
18. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P, (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370: 1773-1779.
19. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG, (2010) C-reactive protein and risk of venous thromboembolism in the general population. Arterioscler Thromb Vasc Biol 30: 1672-1678.
20. Grainge MJ, West J, Card TR, (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375: 657-663.
21. Saleh T, Matta F, Yaekoub AY, Danescu SC, Stein PD, (2010) Risk of Venous Thromboembolism With Inflammatory Bowel Disease. Clin Appl Thromb Hemost.
22. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.
23. Nuttall M, van der Meulen J, Emberton M, (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59: 265-273.
24. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjonneland A, et al. (2010) Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 63: 223-228.
25. Brauchli YB, Jick SS, Miret M, Meier CR, (2009) Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 129: 2604-2612.
26. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695.
27. Lippi G, Favaloro EJ, Montagnana M, Franchini M, (2010) Review: C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med.
28. Berrettini M, Parise P, Constantini V, Grasselli S, Nenci GG, (1985) Platelet activation in psoriasis. Thromb Haemost 53: 195-197.
29. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, et al. (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52: 262-267.
30. Shirinsky IV, Shirinsky VS, (2007) Efficacy of simvastatin in plaque psoriasis: A pilot study. J Am Acad Dermatol 57: 529-531.
31. Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, et al. (2010) Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 31: 1248-1256.
32. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, et al. (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143: 1493-1499.
33. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, et al. (2009) More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 161: 1-7.